Financial Performance - Full Year 2022 - eXp World Holdings reported revenue of $4.6 billion, a 22% year-over-year increase[18, 31] - eXp North American Realty contributed $4.55 billion in revenue, representing approximately 99% of eXp World Holdings' total revenue, also a 22% year-over-year increase[18, 31] - eXp International Realty's revenue grew by 102% year-over-year to $36 million[31] - Adjusted EBITDA for eXp World Holdings was positive, although it decreased by 22% year-over-year to $60.5 million[18, 32, 34] - The company's gross margin increased by 24% to $366.9 million[34, 35] Financial Performance - Q4 2022 - Q4 2022 revenue was $933 million, a 13% decrease compared to the previous year[37, 39] - Adjusted EBITDA for Q4 2022 was $3.6 million, a 73% decrease year-over-year[37, 39] - eXp North American Realty's Q4 revenue was $920.7 million, a 14% decrease year-over-year[37] Agent Network and Operational Metrics - The agent count increased by 21% year-over-year, reaching over 86,000 agents[18, 34, 35, 39, 40, 42] - The company's agent Net Promoter Score (aNPS) was 71 for the full year and 73 for Q4[22, 34, 39] - The number of units sold was 511,889 for the full year, a 15% increase year-over-year, but decreased by 13% to 109,168 units in Q4[34, 39]

Company Overview - WEC Energy Group serves 4.5 million customers [4] - The company has assets of $31 billion [4] - Nearly 70% of the company's assets are located in Wisconsin [4] - WEC Energy Group is the 8th largest natural gas distribution utility in the U S [4] - It is also the 13th largest publicly traded utility in the U S [4] Financial Performance and Growth - The company targets 5-7 percent long-term EPS growth with minimal impact to base rates [3] - WEC Energy Group has demonstrated an 8% CAGR in EPS growth [6] - The company projects dividend growth to be in line with earnings growth [3] - There is no need to issue additional equity through the forecast period [3] Capital Investments and Clean Energy Initiatives - The company has a robust capital plan of $11.8 billion for 2018-2022 [13] - $5 billion (42%) is allocated to Gas Distribution [13] - $2.5 billion (21%) is allocated to Generation [13] - $2.5 billion (21%) is allocated to Electric Distribution [13] - $0.9 billion (8%) is allocated to Technology [13] - $0.9 billion (8%) is allocated to Energy Infrastructure [13] - The company plans to retire more than 1,800 megawatts of coal-fueled generation by 2020 [14] - The company plans to add more than 400 megawatts of natural gas-fueled generation by 2022 [14] - The company plans to invest in more than 350 megawatts of zero-carbon generation in Wisconsin [14] - The company aims to reduce CO₂ emissions to 40% below 2005 levels by 2030 and 80% below 2005 levels by 2050 [16] Shareholder Returns - WEC Energy Group's fifteen-year total shareholder return is 724 2% [10]

Company Overview - WEC Energy Group is the 13th largest publicly traded utility in the U S [7] - The company serves 4 5 million customers [9] - The company has approximately $31 billion in assets, with nearly 70 percent of assets located in Wisconsin [9] - WEC Energy Group is the 8th largest natural gas distribution utility in the U S [9] Financial Performance and Growth - The company has demonstrated a decade of EPS growth [11, 12] with 8% CAGR - The company has shown industry-leading dividend growth, marking the 15th consecutive year of increased dividends in 2018 [13, 14] - WEC Energy Group's fifteen-year total shareholder return is 724 2% [15] Capital Plan and Investments - The company has a robust, executable capital plan for 2018-2022 totaling $11 8 billion [19, 25] - The capital plan allocates $2 5 billion (21%) to generation [21, 24, 25], $5 0 billion (42%) to gas distribution [24, 25], $0 9 billion (8%) to technology [22, 24, 25], $2 5 billion (21%) to electric distribution [24], and $0 9 billion (8%) to energy infrastructure [25] Environmental Goals - The company is achieving its carbon reduction goals [26, 27]

Business Overview - Research Solutions provides an end-to-end AI platform for research, aiming to advance the world's knowledge by simplifying research[31, 34] - The company's mission is to simplify research in a market with exploding research volume and AI inaccuracies[34, 51] - The company serves over 1,500 leading research organizations across 70 countries[40] Market Opportunity - The total addressable market is $15 billion, split between $11 billion for B2B customers and $4 billion for B2C customers[70, 71] - Research-focused SaaS is projected to grow at a CAGR of 18.7%, from $273.55 billion in 2023 to $908.21 billion by 2030[73] Financial Performance - The company's total revenue is $48.8 million (TTM as of 03/31/25)[134] - The company's adjusted EBITDA is $5.1 million (TTM)[134] - The company's annual recurring revenue has grown consistently, reaching $20.4 million in Q3 FY25[125] - The company's cash and equivalents as of March 31, 2025, were $0.9 million[132] - The company's total assets as of March 31, 2025, were $45.2 million[132] Business Model - The company operates with a platform and transactions business model, with transactions accounting for 63% of revenue and the platform accounting for 37% of revenue[92, 96]

Business Overview - Research Solutions operates a SaaS platform and a legacy article (transactions) business, serving primarily North America, EMEA, and Japan[11] - The company's platform business boasts nearly 4x the gross margin of the traditional transaction business, with a SaaS growth rate exceeding 30%+[36] - The company has a strong balance sheet with $10.6 million in cash and no outstanding debt[12] Market Opportunity - The company estimates a total addressable market (TAM) of approximately 700,000 SMBs worldwide, with current penetration less than 1%[12] - The company estimates that ~4% penetration into the SMB market would equate to ~$280 million in annual recurring revenue[26] - The company estimates the platform market to be ~$7 billion[26] Financial Performance - The company's annual recurring revenue (ARR) from platform subscriptions is approximately $7.9 million[20,30] - The company's platform business has a high retention rate and over 100% net retention[20,48] - The company's TTM revenue is $32.9 million[40] - The company's TTM gross margin for the platform business is 86.2%[20,40] - The company's TTM gross margin for the transaction business is 23.6%[40] Key Stats - The company's stock price as of 9/23/22 was $1.86[50] - The company's market capitalization is $50.4 million[50] - The company's enterprise value is $39.8 million[50]

Financial Performance and Goals - Evolus aims to achieve over 20% non-GAAP operating income with at least $700 million in revenue by 2028[10] - The company is targeting $700 million in global sales by 2028, representing a 28% CAGR from 2023[20] - Evolus expects to launch Evolysse and gain approval within the next 12 months[10] - The company's revenue guidance for 2024 is between $260 million and $270 million[21] Market and Product Expansion - The total addressable market for injectables is projected to reach $10 billion by 2028[20] - Evolus plans to expand internationally to achieve $100 million in international revenue by 2028[23] - The company has filed for filler approval with a launch planned in the second half of 2025[23] Clinical Study Results - In a Phase III study, Jeuveau demonstrated non-inferiority to Botox, with responder rates of 87.2% for Jeuveau and 82.8% for Botox at day 30[38] - A post-hoc analysis of a Phase III clinical study showed comparable results between Jeuveau and Botox in improving glabellar line scale and subject satisfaction[44, 48] Evolysse Dermal Fillers - US NLF pivotal study results for Evolysse Form vs Restylane-L showed non-inferiority at 6 months[120] - US NLF pivotal study results for Evolysse Smooth vs Restylane-L also met the primary endpoint of non-inferiority at 6 months[128]

Market and Growth - The total addressable market expands by 78% with the addition of injectable HA gel portfolio[16] - The neurotoxin market is growing to $6 billion in 2028, with a 13% CAGR from 2023[21] - The fillers market is growing to approximately $4 billion in 2028, with a 10% CAGR from 2023[21] - Evolus International is expected to achieve $100 million in 2028[23] Financial Performance and Projections - Evolus expects total net revenues for 2025 to be between $345 million and $355 million[28,112] - Q4 2024 net revenue reached $79 million, a 30% year-over-year increase[106] - The company projects at least $700 million total net revenue by 2028[113,115] - The company projects a non-GAAP operating income margin of at least 20% by 2028[113,115] Product and Strategy - Jeuveau's share of the toxin market has grown from 4% in 2019 to 13% in 2024[19] - 70% of toxin consumers also use a dermal filler[71] - Evolus Rewards program has approximately 1.1 million total enrollments[59,107]

Merger Overview - Uniti and Windstream will combine to create a premier fiber provider with approximately $4 billion in revenue and 236,000 fiber route miles across 47 states in the U S[18] - Existing Uniti shareholders will own about 62% and Windstream shareholders will own about 38% of the combined company's common equity[18] - Windstream shareholders will receive $425 million in cash, $575 million of preferred equity, and common shares representing approximately 38% ownership of the combined company[32] Financial Profile - New Uniti's Fiber Core Revenue for YTD 2024 is $1495 million, a 1 1% increase from $1478 million in YTD 2023[23] - New Uniti's Adjusted EBITDA for YTD 2024 is $916 million, a 5 0% increase from $872 million in YTD 2023[23] - The company projects 2028 revenue of $4 1 billion and Adjusted EBITDA of $2 0 billion[27] Synergies and Growth - The merger aims for up to $100 million in annual operating expense synergies and $20-30 million in annual capital expenditure synergies[52] - Kinetic has upgraded approximately 1 6 million households to Next-gen FTTH[42] - Kinetic's cost per passing is approximately $650[42]

Forward-Looking Statements Certain statements in this communication may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended from time to time. Those forward-looking statements include all statements that are not historical statements of fact, including, without limitation, statements regarding the anticipated closing of the merger of Uniti and Windstream (the "Merger") and the future performance of Uniti, Windstream and the combined co ...

Corporate Presentation June 2025 Forward-looking Statement This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended, including without limitation, statements regarding, among other things, the potential number of patients who could be treated by tebipenem HBr and market demand for tebipenem HBr generally; the potential regulatory path forward for tebipenem HBr, the potential approval of tebipenem HBr by the U.S. Food and Drug Admini ...